| Polymorphs, salts, and cocrystals: what’s in a name? S Aitipamula, R Banerjee, AK Bansal, K Biradha, ML Cheney, ... Crystal growth & design 12 (5), 2147-2152, 2012 | 1170 | 2012 |
| A means to address regional variability in intestinal drug absorption G Chawla, A Bansal Pharm tech 27 (2), 50-68, 2003 | 515 | 2003 |
| Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids B Shah, VK Kakumanu, AK Bansal Journal of pharmaceutical sciences 95 (8), 1641-1665, 2006 | 467 | 2006 |
| Amorphous drug delivery systems: molecular aspects, design, and performance AM Kaushal, P Gupta, AK Bansal Critical Reviews™ in Therapeutic Drug Carrier Systems 21 (3), 2004 | 367 | 2004 |
| Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model B Wahlang, YB Pawar, AK Bansal European Journal of Pharmaceutics and Biopharmaceutics 77 (2), 275-282, 2011 | 304 | 2011 |
| Compression physics in the formulation development of tablets S Patel, AM Kaushal, AK Bansal Critical Reviews™ in therapeutic drug carrier systems 23 (1), 2006 | 301 | 2006 |
| Coprocessed excipients for solid dosage forms SK Nachaegari, AK Bansal Pharmaceutical technology (2003) 28 (1), 52-64, 2004 | 278 | 2004 |
| Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective P Gupta, VK Kakumanu, AK Bansal Pharmaceutical research 21, 1762-1769, 2004 | 269 | 2004 |
| Trends in pharmaceutical taste masking technologies: a patent review Z Ayenew, V Puri, L Kumar, AK Bansal Recent patents on drug delivery & formulation 3 (1), 26-39, 2009 | 233 | 2009 |
| Characterization of solid-state forms of celecoxib G Chawla, P Gupta, R Thilagavathi, AK Chakraborti, AK Bansal European Journal of Pharmaceutical Sciences 20 (3), 305-317, 2003 | 208 | 2003 |
| Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility P Gupta, G Chawla, AK Bansal Molecular pharmaceutics 1 (6), 406-413, 2004 | 195 | 2004 |
| Effect of particle size and compression force on compaction behavior and derived mathematical parameters of compressibility S Patel, AM Kaushal, AK Bansal Pharmaceutical research 24, 111-124, 2007 | 186 | 2007 |
| Drug-excipient behavior in polymeric amorphous solid dispersions SB Teja, SP Patil, G Shete, S Patel, AK Bansal International Journal of Pharmaceutical Excipients 4 (3), 2016 | 178 | 2016 |
| Excipients used in lyophilization of small molecules. A Baheti, L Kumar, AK Bansal Journal of Excipients & Food Chemicals 1 (1), 2010 | 166 | 2010 |
| Role of molecular interaction in stability of celecoxib− PVP amorphous systems P Gupta, R Thilagavathi, AK Chakraborti, AK Bansal Molecular pharmaceutics 2 (5), 384-391, 2005 | 165 | 2005 |
| SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection RP Joshi, G Negi, A Kumar, YB Pawar, B Munjal, AK Bansal, SS Sharma Nanomedicine: Nanotechnology, Biology and Medicine 9 (6), 776-785, 2013 | 160 | 2013 |
| Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples G Shete, V Puri, L Kumar, AK Bansal AAPS PharmSciTech 11 (2), 598-609, 2010 | 153 | 2010 |
| Self-emulsifying drug delivery systems: a strategy to improve oral bioavailability K Sarpal, YB Pawar, AK Bansal Current Research & Information on Pharmaceuticals Sciences (CRIPS) 11 (3), 42-49, 2010 | 131 | 2010 |
| Quantification of olanzapine polymorphs using powder X-ray diffraction technique M Tiwari, G Chawla, AK Bansal Journal of pharmaceutical and biomedical analysis 43 (3), 865-872, 2007 | 126 | 2007 |
| Challenges in translational development of pharmaceutical cocrystals DP Kale, SS Zode, AK Bansal Journal of pharmaceutical sciences 106 (2), 457-470, 2017 | 124 | 2017 |
Lokesh kumarGenentech Inc在 gene.com 的电子邮件经过验证